Medtronic landed FDA approval for its Specify SureScan MRI surgical leads for use with the firm’s spinal cord neurostimulators to treat chronic pain. The approval allows patients with MRI-compatible stimulators to receive full-body scans, given that certain precautions are taken. This approval now establishes Medtronic as having a complete line of MRI-approved neurostimulation systems, allowing physicians to choose the optimal solution knowing that the patient will be able to receive scans in the future.
“All patients with a spinal cord stimulation system should have the ability to be offered the same imaging options as those without one,” said Steven Falowski, M.D., neurosurgeon at St. Luke’s University Health Network in Bethlehem, Pennsylvania, in the announcement. “Now more than ever, patients and other health care providers are concerned about access to MRI when considering an implantable device. This approval means I can offer a neurostimulation system that helps manage my patients’ pain and gives them access to the diagnostic benefits of MRI.”
Via: Medtronic…